SCHEMBL7650135

SCHEMBL7650135

O=C(c1cncc(C(=O)N(CCO)CCO)c1)N(CCO)CCO

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NTRK2 Q16620 1/20 0.44
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALPL P05186 2/20 0.35
KDM4E B2RXH2 3/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CA2 P00918 1/20 0.35
CYP3A4 P08684 1/20 0.35
HCAR2 Q8TDS4 4/20 0.34
POLB P06746 1/20 0.34
LMNA P02545 1/20 0.34
DDO Q99489 1/20 0.34
CASP3 P42574 1/20 0.34
CFTR P13569 1/20 0.33
LIMK2 P53671 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2781653 0.82 ROCK1 (0.37) NTRK2CYP2C9CYP2C19KDM4EKMT2A
SCHEMBL10875034 0.82 POLB (0.47) CYP2C19KDM4EKMT2ACYP3A4HCAR2
SCHEMBL10876070 0.81 HCAR2 (0.46) ALPLKDM4EALDH1A1HCAR2CASP3
SCHEMBL7662074 0.81 KMT2A (0.45) CYP2C9CYP2C19KDM4EKMT2AMEN1
SCHEMBL10874128 0.80 POLB (0.49) CYP2C19KDM4EKMT2ACYP3A4HCAR2
SCHEMBL9525018 0.80 POLB (0.45) CYP2C19KDM4EKMT2AALDH1A1CYP3A4
SCHEMBL10873474 0.79 HPGD (0.48) KDM4EKMT2AMEN1ALDH1A1HCAR2
SCHEMBL4745639 0.78 ALDH1A1 (0.52) KDM4EKMT2AMEN1ALDH1A1HCAR2
SCHEMBL5127047 0.77 CYP2C9 (0.53) CYP2C9CYP2C19KDM4EKMT2AMEN1
SCHEMBL7157289 0.76 ALDH1A1 (0.48) NTRK2KMT2AMEN1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed